ADAMS R MARK 4
4 · Adaptive Biotechnologies Corp · Filed Oct 11, 2022
Insider Transaction Report
Form 4
ADAMS R MARK
Chief Technical Officer
Transactions
- Sale
Common Stock
2022-10-07$7.61/sh−841$6,400→ 118,927 total - Sale
Common Stock
2022-10-10$7.13/sh−2,284$16,285→ 116,643 total
Footnotes (2)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022.